ARCHIVES

Study Shows MammaPrint Test Can Predict 25-Year Risk Levels

This article is from The Cancer Letter archive.

Vol. 37 No. 2 | February 28, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Proposal To Regulate Tobacco Wins Support Of NCI, Oncology Societies

September 8, 1995

New Technology May Enable Therapy Tailored To Patient’s Predicted Response

April 26, 2002

HHS Drops Misconduct allegations Against NCI’s Gallo Days Before Appeals Hearing

November 19, 1993

Burton Clinic Shit Down Seven Year After PAHO Report

August 2, 1985

ACS Research Budget Over $82 Million

July 17, 1987

FDA Approves Avastin Combination For Late-Stage Cervical Cancer

August 29, 2014